WT-1 was initially discovered as a tumor suppressor in Wilms’ tumor, and is expressed in most serous adenocarcinomas of the ovary and peritoneum and mesotheliomas, as well as in Wilms’ tumors. The gene discussed is WT1; the disease is Wilms tumor.